NYSTATIN

Generic: NYSTATIN

Major PharmaceuticalsManufacturer
ORALRoute
NYSTATINActive Substance
2016-01-07Original Approval

NYSTATIN is FDA application ANDA203621, sponsored by PHARM ASSOC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
NAUSEA
2,027 reports
2
FATIGUE
1,796 reports
3
DIARRHOEA
1,794 reports
4
PNEUMONIA
1,646 reports
5
DYSPNOEA
1,490 reports
6
OFF LABEL USE
1,482 reports
7
VOMITING
1,399 reports
8
DRUG INEFFECTIVE
1,299 reports
9
PAIN
1,234 reports
10
DEATH
1,155 reports